BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 28351328)

  • 1. Effect of EBI3 on radiation-induced immunosuppression of cervical cancer HeLa cells by regulating Treg cells through PD-1/PD-L1 pathway.
    Zhang SA; Niyazi HE; Hong W; Tuluwengjiang GL; Zhang L; Zhang Y; Su WP; Bao YX
    Tumour Biol; 2017 Mar; 39(3):1010428317692237. PubMed ID: 28351328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between PD-1/PD-L1 and T regulate cells in early recurrent miscarriage.
    Li G; Lu C; Gao J; Wang X; Wu H; Lee C; Xing B; Zhang Q
    Int J Clin Exp Pathol; 2015; 8(6):6512-8. PubMed ID: 26261529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-374b increases the CIK expression and mediates biological function changes in cervical cancer cells by targeting the PD-1/PD-L1 signaling pathway.
    Wang C; Kuang L; Han L
    J Reprod Immunol; 2021 Feb; 143():103265. PubMed ID: 33360511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PD-1 upregulated on regulatory T cells during chronic virus infection enhances the suppression of CD8+ T cell immune response via the interaction with PD-L1 expressed on CD8+ T cells.
    Park HJ; Park JS; Jeong YH; Son J; Ban YH; Lee BH; Chen L; Chang J; Chung DH; Choi I; Ha SJ
    J Immunol; 2015 Jun; 194(12):5801-11. PubMed ID: 25934860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High and interrelated rates of PD-L1+CD14+ antigen-presenting cells and regulatory T cells mark the microenvironment of metastatic lymph nodes from patients with cervical cancer.
    Heeren AM; Koster BD; Samuels S; Ferns DM; Chondronasiou D; Kenter GG; Jordanova ES; de Gruijl TD
    Cancer Immunol Res; 2015 Jan; 3(1):48-58. PubMed ID: 25361854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nodal metastasis in cervical cancer occurs in clearly delineated fields of immune suppression in the pelvic lymph catchment area.
    Heeren AM; de Boer E; Bleeker MC; Musters RJ; Buist MR; Kenter GG; de Gruijl TD; Jordanova ES
    Oncotarget; 2015 Oct; 6(32):32484-93. PubMed ID: 26431490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-21 Participates in the PD-1/PD-L1 Pathway-Mediated Imbalance of Th17/Treg Cells in Patients After Gastric Cancer Resection.
    Zheng X; Dong L; Wang K; Zou H; Zhao S; Wang Y; Wang G
    Ann Surg Oncol; 2019 Mar; 26(3):884-893. PubMed ID: 30565043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PD-1 Blockade Boosts Radiofrequency Ablation-Elicited Adaptive Immune Responses against Tumor.
    Shi L; Chen L; Wu C; Zhu Y; Xu B; Zheng X; Sun M; Wen W; Dai X; Yang M; Lv Q; Lu B; Jiang J
    Clin Cancer Res; 2016 Mar; 22(5):1173-1184. PubMed ID: 26933175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The increase of circulating PD-L1-expressing CD68(+) macrophage in ovarian cancer.
    Qu QX; Huang Q; Shen Y; Zhu YB; Zhang XG
    Tumour Biol; 2016 Apr; 37(4):5031-7. PubMed ID: 26541760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of programmed cell death 1 and programmed cell death ligand 1 in extranodal NK/T-cell lymphoma, nasal type.
    Jo JC; Kim M; Choi Y; Kim HJ; Kim JE; Chae SW; Kim H; Cha HJ
    Ann Hematol; 2017 Jan; 96(1):25-31. PubMed ID: 27696202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of PD-1/PD-L1 Signaling Pathway with Treg/Th17 Imbalance from Asthmatic Children.
    Xi X; Liu JM; Guo JY
    Int Arch Allergy Immunol; 2018; 176(3-4):255-267. PubMed ID: 29874664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PD-1, PD-L1 and PD-L2 Gene Expression on T-Cells and Natural Killer Cells Declines in Conjunction with a Reduction in PD-1 Protein during the Intensive Phase of Tuberculosis Treatment.
    Hassan SS; Akram M; King EC; Dockrell HM; Cliff JM
    PLoS One; 2015; 10(9):e0137646. PubMed ID: 26359860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Association Between PD-L1 Expression and the Clinical Outcomes to Vascular Endothelial Growth Factor-Targeted Therapy in Patients With Metastatic Clear Cell Renal Cell Carcinoma.
    Shin SJ; Jeon YK; Cho YM; Lee JL; Chung DH; Park JY; Go H
    Oncologist; 2015 Nov; 20(11):1253-60. PubMed ID: 26424759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of Programmed Death-1 and Its Ligand in Cardiac Injury Models: Interaction with GADD153.
    Baban B; Liu JY; Qin X; Weintraub NL; Mozaffari MS
    PLoS One; 2015; 10(4):e0124059. PubMed ID: 25902191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of PD-1 on CD4⁺CD25⁺ T cells is associated with immunosuppression in liver of mice infected with Echinococcus multilocularis.
    La X; Zhang F; Li Y; Li J; Guo Y; Zhao H; Pang N; Ma X; Wen H; Fan H; Ding J
    Int Immunopharmacol; 2015 Jun; 26(2):357-66. PubMed ID: 25907244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The altered PD-1/PD-L1 pathway delivers the 'one-two punch' effects to promote the Treg/Th17 imbalance in pre-eclampsia.
    Zhang Y; Liu Z; Tian M; Hu X; Wang L; Ji J; Liao A
    Cell Mol Immunol; 2018 Jul; 15(7):710-723. PubMed ID: 28890543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PD-1 and PD-L1 upregulation promotes CD8(+) T-cell apoptosis and postoperative recurrence in hepatocellular carcinoma patients.
    Shi F; Shi M; Zeng Z; Qi RZ; Liu ZW; Zhang JY; Yang YP; Tien P; Wang FS
    Int J Cancer; 2011 Feb; 128(4):887-96. PubMed ID: 20473887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Let‑7a suppresses cell proliferation via the TGF‑β/SMAD signaling pathway in cervical cancer.
    Wu T; Chen X; Peng R; Liu H; Yin P; Peng H; Zhou Y; Sun Y; Wen L; Yi H; Li A; Zhang Z
    Oncol Rep; 2016 Dec; 36(6):3275-3282. PubMed ID: 27748903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human umbilical vein endothelial cells promote the inhibitory activation of CD4(+)CD25(+)Foxp3(+) regulatory T cells via PD-L1.
    Chen WJ; Hu XF; Yan M; Zhang WY; Mao XB; Shu YW
    Atherosclerosis; 2016 Jan; 244():108-12. PubMed ID: 26615520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expressions of Immune Negative Regulator FoxP3+Treg and PD-L1 Protein in the Immune Microenvironment of Cervical Lesion.
    Ma Q; Zhao M; Wei X; Zhao J; Yang T; Zhang Q; Wang K; Yang X
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Feb; 39(1):128-132. PubMed ID: 28270295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.